|
News GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily Relovair in COPD and asthma
GlaxoSmithKline and Theravance, Inc. announced the completion of the phase III registration programme for the once-daily investigational medicine Relovair |
|
Leaflet Drug Avamys
Avamys is a nasal spray that contains the active substance fluticasone furoate. |
|
Article Fluticasone Propionate (micronized)
Fluticasone Propionate (micronized) - Description and Solubility (according Pharmacopoeia). Physical properties of Fluticasone Propionate (micronized) |